- Lobbying
- Lobbying by CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
Lobbying Relationship
Bills mentioned
S.2315: Over-the-Counter Drug Safety, Innovation, and Reform Act
Sponsor: Johnny Isakson (R-Ga.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Wade Ackerman | Sr. FDA Counsel, US Senate Committee on Health, Education, Labor & Pensions. |
Richard Kingham | n/a |
Jennifer Zachary | n/a |
Elizabeth Guo | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate